How Overseas Pharma Companies Can Leverage CROs to Enter the Korea Market
Developing new drugs is a complex, resource-intensive process requiring significant time and investment. For overseas pharmaceutical companies aiming to penetrate Korea’s thriving market, conducting clinical trials independently poses challenges due to unfamiliar regulations and limited local resources. Partnering strategically with…